<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title><![CDATA[Piramal Enterprises Limited 보도자료 - 뉴스와이어]]></title><link>https://www.newswire.co.kr/?md=A10&amp;act=article&amp;no=27728></link><description><![CDATA[Piramal Enterprises Limited 보도자료 - 뉴스와이어 RSS 서비스]]></description><lastBuildDate>Fri, 15 May 2026 06:59:08 +0900</lastBuildDate><copyright>Copyright (c) 2004~2026 Korea Newswire All rights reserved</copyright><image><url><![CDATA[https://file.newswire.co.kr/data/upfile/company_img/2016/08/3554153577_20160817155939_6025697674.jpg]]></url></image><language>ko-KR</language><item><title><![CDATA[Piramal Enterprises Enters into an Agreement to Acquire Ash Stevens Inc., a US based CDMO for High Potency APIs (HPAPIs)]]></title><link>https://www.newswire.co.kr/newsRead.php?no=833346</link><description><![CDATA[MUMBAI, India--(Business Wire/Korea Newswire)--Piramal Enterprises Limited (PEL, NSE: PEL, BSE: 500302) announced today that its wholly owned subsidiary in the US has entered into an agreement to acquire 100% stake in Ash Stevens Inc., a US based Contract Development and Manufacturing Organization (CDMO), in an all cash deal for a consideration of USD 42.95 million plus an earn-out considera...]]></description><pubDate>Wed, 17 Aug 2016 16:00:00 +0900</pubDate></item><item><title><![CDATA[피라말 엔터프라이즈, 고효능 활성 원료의약품(HPAPI) 확보 위해 미국 의약품 위탁개발 및 생산 기업(CDMO)인 애쉬 스티븐스 인수 계약 체결]]></title><link>https://www.newswire.co.kr/newsRead.php?no=833347</link><description><![CDATA[뭄바이, 인도--(Business Wire/뉴스와이어)--피라말 엔터프라이즈(Piramal Enterprises Limited, 이하 ‘PEL’)(인도증권거래소: PEL, 봄베이증권거래소: 500302)가 오늘 자사의 미국 내 완전소유 자회사가 미국에 기반을 둔 의약품 전문 위탁개발 및 생산 기업(Contract Development and Manufacturing Organization, CDMO)인 애쉬 스티븐스(Ash Stevens Inc.)의 지분 100%를4295만 달러의 현금과 최대 1000만 달러를 언...]]></description><pubDate>Wed, 17 Aug 2016 16:00:00 +0900</pubDate></item></channel></rss>